Events

 

MaRS Future of Medicine™

The monthly MaRS Future of Medicine™ Series is a vibrant forum for sharing experiences and best practices relating to drug and device development.

Each event consists of a 30 minute presentation followed by an opportunity for interactive discussion.

Since 2006, the MaRS Future of Medicine™ Series has covered a wide range of important topics ranging all the way from structure-based drug discovery to reimbursement.

MaRS Future of Medicine™ Series is a must-attend event for anyone engaged in translational research or commercial development within the life sciences.

Where:
MaRS Discovery District
101 College Street, Toronto

Past Events

MaRS Programming
May 14, 2012
MaRS Future of Medicine™
Assessing Breast Cancer Risk
>
MaRS Programming
Apr 11, 2012
MaRS Future of Medicine™
Why did they invest in that?
>
MaRS Programming
Mar 13, 2012
MaRS Future of Medicine™
How Digital Tools are Transforming the Way We Do Science
>
MaRS Programming
Feb 14, 2012
MaRS Future of Medicine™
Personalized Cancer Treatment
>
MaRS Programming
Jan 10, 2012
MaRS Future of Medicine™
The Renaissance of Gene Therapy
>
MaRS Programming
Nov 24, 2011
MaRS Future of Medicine™
Building a Self-Sustaining Medical Research Engine: The Ontario Cancer Biomarker Network
>
MaRS Programming
Nov 17, 2011
MaRS Future of Medicine™
MaRS Future of Medicine™ Conference 2011
>
MaRS Programming
Oct 27, 2011
MaRS Future of Medicine™
Financing Early Stage Companies in Challenging Times
>
MaRS Programming
Sep 29, 2011
MaRS Future of Medicine™
Truths and Myths about Life Science Venture Capital
>
MaRS Programming
Aug 25, 2011
MaRS Future of Medicine™
Teaching old drugs new tricks – developing new therapies for patients with leukemia
>
MaRS Programming
Jul 28, 2011
MaRS Future of Medicine™
Adventures in Private Biotech Financing – A company perspective
>
MaRS Programming
May 26, 2011
MaRS Future of Medicine™
Lessons from the Device Battlefield
>
MaRS Programming
Apr 29, 2011
MaRS Future of Medicine™
What does Pharma want, anyway? Presenting your opportunity effectively
>
MaRS Programming
Mar 31, 2011
MaRS Future of Medicine™
Private capital for life science companies
>
MaRS Programming
Feb 24, 2011
MaRS Future of Medicine™
CCRM: Open source innovation in regenerative medicine
>
MaRS Programming
Dec 02, 2010
MaRS Future of Medicine™
MaRS Future of Medicine Conference 2010
>
MaRS Programming
Dec 01, 2010
MaRS Future of Medicine™
What you need to know about regulatory affairs
>
MaRS Programming
Nov 01, 2010
MaRS Future of Medicine™
The View from Bay Street
>
MaRS Programming
Sep 10, 2010
MaRS Future of Medicine™
Anticipating a world in which pharmaceutical companies outsource all R&D
>
MaRS Programming
Aug 24, 2010
MaRS Future of Medicine™
QANTD (Quick And Not Too Dirty) Forecasting
>
 
Jul 26, 2010
MaRS Future of Medicine™
Lessons Learned as an Entrepreneur
>
MaRS Programming
Jun 04, 2010
MaRS Future of Medicine™
Cytochrome-targeted therapeutics for chronic kidney disease
>
MaRS Programming
May 27, 2010
MaRS Future of Medicine™
International Symposium on Nitric Oxide and Other Gaseous Neurotransmitters
>
MaRS Programming
Apr 05, 2010
MaRS Future of Medicine™
A new approach to the treatment of liver cancer
>
MaRS Programming
Mar 12, 2010
MaRS Future of Medicine™
Predicting disease outcome via gene expression analysis
>
MaRS Programming
Feb 12, 2010
MaRS Future of Medicine™
Leading 21st century health care, non-invasive treatment for prostate cancer
>
MaRS Programming
Dec 02, 2009
MaRS Future of Medicine™
Health Economic and Reimbursement Implications for Emerging Pharmaceutical/ Biotechnology Companies: Strategies and perspectives
>
MaRS Programming
Nov 13, 2009
MaRS Future of Medicine™
Targeting Alzheimer’s Disease Progression – from a lead molecule to clinical development
>
MaRS Programming
Nov 12, 2009
MaRS Future of Medicine™
MaRS Future of Medicine Conference
>
MaRS Programming
Oct 09, 2009
MaRS Future of Medicine™
Human pluripotent stem cells for drug discovery
>
 
Sep 17, 2009
MaRS Future of Medicine™
Revitalizing drug discovery with in vivo screening
>
MaRS Programming
Sep 11, 2009
MaRS Future of Medicine™
CHEMSAS® system for drug lead optimization
>
MaRS Programming
Jul 06, 2009
MaRS Future of Medicine™
Disease specific epitopes immunotherapies
>
MaRS Programming
Jun 01, 2009
MaRS Future of Medicine™
Controlled trans-lymphatic chemotherapy for the treatment of lymphatic metastasis in lung cancer
>
MaRS Programming
May 15, 2009
MaRS Future of Medicine™
Overcoming process development and biologics manufacturing challenges
>
MaRS Programming
Dec 16, 2008
MaRS Future of Medicine™
Is there a place for in-vivo pharmacology in modern drug discovery?
>
MaRS Programming
Mar 27, 2008
MaRS Future of Medicine™
Structure-Guided Discovery Without Structures: Computer-aided design of GPCR ligands
>
MaRS Programming
Feb 27, 2008
MaRS Future of Medicine™
Formulation: Giving new life to naturally occurring un-patentable compounds
>
MaRS Programming
Jan 25, 2008
MaRS Future of Medicine™
Novel therapeutic targets for preventing bone loss in osteolytic disease
>
MaRS Programming
Dec 18, 2007
MaRS Future of Medicine™
Outsourcing Preclinical Development
>
MaRS Programming
Oct 23, 2006
MaRS Future of Medicine™
Chance and Necessity in Drug Discovery: The case history of calcimimetic drugs
>
MaRS Programming
Aug 31, 2006
MaRS Future of Medicine™
Structure-based Lead Generation and Optimization
>
MaRS Programming
Jun 29, 2006
>
MaRS Programming
Apr 27, 2006
MaRS Future of Medicine™
BioMarkers in Clinical Trials
>
 
SUBMIT AN EVENT
 
SPONSOR AN EVENT
 
REQUEST A RESERVATION
 
 
Get More From MaRS   MaRS NEWSLETTERS
Facebook Twitter Vimeo Flickr

MaRS Charitable Registration Number
876682717 RR0001

Please enter your email address to subscribe to our newsletter